Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-07

Clinical Trial Update: Varenicline and Bupropion for Alcohol Use Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a varenicline and bupropion combination for alcohol use disorder has completed with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varenicline (varenicline)
  • bupropion (bupropion)

Snippet

Sponsor: Vastra Gotaland Region | Conditions: Alcohol Use Disorder, Alcoholism | Phase 2 | Status: COMPLETED | Results posted: 2024-06-07